BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Swiatly A, Plewa S, Matysiak J, Kokot ZJ. Mass spectrometry-based proteomics techniques and their application in ovarian cancer research. J Ovarian Res 2018;11:88. [PMID: 30270814 DOI: 10.1186/s13048-018-0460-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Xiu L, Li N, Wang W, Chen F, Yuan G, Cui W, Wu L. Identification of serum peptide biomarkers for predicting the efficacy of first-line chemotherapy in advanced epithelial ovarian cancer by MALDI-TOF-MS with magnetic bead technology.. [DOI: 10.21203/rs.3.rs-2224958/v1] [Reference Citation Analysis]
2 Wang X, Wang S, Yao S, Shi W, Ma K. The clinical characteristics and treatment of ovarian malignant mesoderm mixed tumor: a systematic review. J Ovarian Res 2022;15. [DOI: 10.1186/s13048-022-01037-6] [Reference Citation Analysis]
3 Acland M, Lokman NA, Young C, Anderson D, Condina M, Desire C, Noye TM, Wang W, Ricciardelli C, Creek DJ, Oehler MK, Hoffmann P, Klingler-hoffmann M. Chemoresistant Cancer Cell Lines Are Characterized by Migratory, Amino Acid Metabolism, Protein Catabolism and IFN1 Signalling Perturbations. Cancers 2022;14:2763. [DOI: 10.3390/cancers14112763] [Reference Citation Analysis]
4 Ghose A, Gullapalli SVN, Chohan N, Bolina A, Moschetta M, Rassy E, Boussios S. Applications of Proteomics in Ovarian Cancer: Dawn of a New Era. Proteomes 2022;10:16. [DOI: 10.3390/proteomes10020016] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 13.0] [Reference Citation Analysis]
5 Thompson M, Ahmadi S, Davoudian K, De La Franier B, Lotay N, Bernardini MQ. Sensor detection in gynaecological medicine. Sens Diagn 2022;1:877-901. [DOI: 10.1039/d2sd00090c] [Reference Citation Analysis]
6 Perez JM, Twigg CAI, Guan W, Thomas SN. Proteomic Analysis Reveals Low-Dose PARP Inhibitor-Induced Differential Protein Expression in BRCA1-Mutated High-Grade Serous Ovarian Cancer Cells. J Am Soc Mass Spectrom . [DOI: 10.1021/jasms.1c00215] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Luu GT, Sanchez LM. Toward improvement of screening through mass spectrometry-based proteomics: ovarian cancer as a case study. Int J Mass Spectrom 2021;469:116679. [PMID: 34744497 DOI: 10.1016/j.ijms.2021.116679] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Ferreira M, Ventorim R, Almeida E, Silveira S, Silveira W. Protein Abundance Prediction Through Machine Learning Methods. J Mol Biol 2021;433:167267. [PMID: 34563548 DOI: 10.1016/j.jmb.2021.167267] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Mukherjee S, Sundfeldt K, Borrebaeck CAK, Jakobsson ME. Comprehending the Proteomic Landscape of Ovarian Cancer: A Road to the Discovery of Disease Biomarkers. Proteomes 2021;9:25. [PMID: 34070600 DOI: 10.3390/proteomes9020025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Hou L, Li H, Wang H, Ma D, Liu J, Ma L, Wang Z, Yang Z, Wang F, Xia H. The circadian clock gene PER2 enhances chemotherapeutic efficacy in nasopharyngeal carcinoma when combined with a targeted nanosystem. J Mater Chem B 2020;8:5336-50. [PMID: 32458942 DOI: 10.1039/d0tb00595a] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
11 Kasimir-Bauer S, Roder J, Obermayr E, Mahner S, Vergote I, Loverix L, Braicu E, Sehouli J, Concin N, Kimmig R, Net L, Roder H, Zeillinger R, Aust S, On Behalf Of The Ovcad Ovarian Cancer Diagnosis Initiative. Definition and Independent Validation of a Proteomic-Classifier in Ovarian Cancer. Cancers (Basel) 2020;12:E2519. [PMID: 32899818 DOI: 10.3390/cancers12092519] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
12 Zhao R, Lin G, Wang Y, Qin W, Gao T, Han J, Qin R, Pan Y, Sun J, Ren C, Ren S, Xu C. Use of the serum glycan state to predict ovarian cancer patients' clinical response to chemotherapy treatment. J Proteomics 2020;223:103752. [PMID: 32209427 DOI: 10.1016/j.jprot.2020.103752] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
13 Elechalawar CK, Hossen MN, McNally L, Bhattacharya R, Mukherjee P. Analysing the nanoparticle-protein corona for potential molecular target identification. J Control Release 2020;322:122-36. [PMID: 32165239 DOI: 10.1016/j.jconrel.2020.03.008] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 10.5] [Reference Citation Analysis]
14 Paananen J, Fortino V. An omics perspective on drug target discovery platforms. Brief Bioinform 2020;21:1937-53. [PMID: 31774113 DOI: 10.1093/bib/bbz122] [Cited by in Crossref: 49] [Cited by in F6Publishing: 54] [Article Influence: 16.3] [Reference Citation Analysis]
15 Liu W, Song Q, Cao Y, Zhao Y, Huo H, Wang Y, Song Y, Li J, Tu P. Advanced liquid chromatography-mass spectrometry enables merging widely targeted metabolomics and proteomics. Analytica Chimica Acta 2019;1069:89-97. [DOI: 10.1016/j.aca.2019.04.013] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
16 Glazko G, Zybailov B, Emmert-Streib F, Baranova A, Rahmatallah Y. Proteome-transcriptome alignment of molecular portraits achieved by self-contained gene set analysis: Consensus colon cancer subtypes case study. PLoS One 2019;14:e0221444. [PMID: 31437237 DOI: 10.1371/journal.pone.0221444] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 Ion L, Petre BA. Immuno-Affinity Mass Spectrometry: A Novel Approaches with Biomedical Relevance. In: Woods AG, Darie CC, editors. Advancements of Mass Spectrometry in Biomedical Research. Cham: Springer International Publishing; 2019. pp. 377-88. [DOI: 10.1007/978-3-030-15950-4_21] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Dang L, Jia L, Zhi Y, Li P, Zhao T, Zhu B, Lan R, Hu Y, Zhang H, Sun S. Mapping human N-linked glycoproteins and glycosylation sites using mass spectrometry. Trends Analyt Chem 2019;114:143-50. [PMID: 31831916 DOI: 10.1016/j.trac.2019.02.009] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
19 Panner Selvam MK, Baskaran S, Agarwal A. Proteomics of reproduction: Prospects and perspectives. Adv Clin Chem 2019;92:217-43. [PMID: 31472755 DOI: 10.1016/bs.acc.2019.04.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]